Chemotherapy: Open Access

Chemotherapy: Open Access
Open Access

ISSN: 2167-7700

+44 1223 790975

Christine Brezden-Masley

Christine Brezden-Masley

Christine Brezden-Masley
Department of Medicine
University of Toronto, Canada


Dr. Christine Brezden-Masley achieved all of her training in Toronto. She completed her PhD in Medical Biophysics at the Ontario Cancer Institute, Princess Margaret Hospital and her MD degree subsequently at the University of Toronto. She completed her Medical Oncology training in Toronto including research with the Investigational New Drug Development program. She currently is appointed at the University of Toronto as an Assistant Professor and is a Staff Medical Oncologist at St. Michael′s Hospital where she specializes in treating both Breast and GI Malignancies.

She is very active in clinical research and holds a CIHR grant studying cardiotoxicity from breast cancer therapy. She is the Head of the Oncology Clinical Research Group, where more than 20 clinical cancer trials are open at SMH and currently accruing patients. She is also the Founder of the COMET (Community Oncologists of Metropolitan Toronto) Clinical Trials Consortium, a virtual community providing access for cancer patients to appropriate cancer clinical trials.

Research Interest

Her research includes studying the molecular pathways in breast and gastric tumorigenesis. She is cross-appointed to the LiKaShing Knowledge Translation Center where she is serves as an oncology specialist for current and future studies. In addition to clinical research, she also has a focus on patient safety and quality improvement as it pertains to cancer delivery at the academic cancer centers at the University of Toronto.